Approval · Notice of Compliance 33767 · 2024
BAVENCIO: Notice of Compliance 33767
Issued August 6, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33767
- Date
- August 6, 2024
- Company
- Emd Serono A Division Of Emd Inc CanadaMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Fulfillment of commitment 2a of the Letter of Undertaking dated April 10, 2018 issued under NDS control number 208742.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BAVENCIO | Not yet assigned | — |
Medicinal ingredients
- AVELUMAB 20 MG per ML